INDOCO · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 8/100 — Quality 12 · Momentum 0
| Share price | ₹244.55 |
| Market cap | ₹2,399 Cr |
| P/B ratio | 2.3 |
| ROCE | 1.0% |
| Dividend yield | 0.08% |
| Book value | ₹111.55 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,845 Cr | ₹-99 Cr | 8.0% |
| 2025 | ₹1,665 Cr | ₹-78 Cr | 6.0% |
| 2024 | ₹1,817 Cr | ₹97 Cr | 13.0% |
| 2023 | ₹1,669 Cr | ₹142 Cr | 17.0% |
| 2022 | ₹1,541 Cr | ₹155 Cr | 21.0% |
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydrati